Suppr超能文献

一种影响钙调蛋白和肌球蛋白轻链激酶功能的新型调节蛋白。

A novel regulatory protein that affects the functions of caldesmon and myosin light chain kinase.

作者信息

Lin Y, Ishikawa R, Kohama K

机构信息

Department of Pharmacology, Gunma University, School of Medicine, Japan.

出版信息

Biochem Biophys Res Commun. 1992 May 15;184(3):1212-8. doi: 10.1016/s0006-291x(05)80011-7.

Abstract

A caldesmon (CaD)-binding protein of about 65 kDa (by SDS-PAGE) was purified from smooth muscle of chicken gizzard. The 65-kDa protein prevented the inhibitory effect of CaD on the ATP-dependent interaction between actin and myosin. Unlike the case with calmodulin (CaM), Ca2+ was not required for this effect. As reported in the preceding communication, myosin light chain kinase (MLCK), another well characterized protein that binds CaM, has CaD-like activity that modulates the interaction by binding to actin. The 65-kDa protein was also effective in relieving the modulation, while leaving unaffected the kinase activity that phosphorylates the light chain of smooth muscle myosin.

摘要

从鸡胗平滑肌中纯化出一种约65 kDa(通过SDS-PAGE)的钙调蛋白(CaD)结合蛋白。该65 kDa蛋白可阻止CaD对肌动蛋白和肌球蛋白之间ATP依赖性相互作用的抑制作用。与钙调素(CaM)的情况不同,此效应不需要Ca2+。如前一篇通讯中所报道,肌球蛋白轻链激酶(MLCK)是另一种与CaM结合的特征明确的蛋白,具有类似CaD的活性,通过与肌动蛋白结合来调节相互作用。该65 kDa蛋白在缓解这种调节方面也有效,同时不影响使平滑肌肌球蛋白轻链磷酸化的激酶活性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验